Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867007077960908800 |
|---|---|
| author | Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt |
| author_facet | Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt |
| collection | Wiley Open Access |
| contents | Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt Contact Dermatitis AbstractIntroductionMedical devices (MDs) have a long history of use, and come with regulatory frameworks to ensure user safety. Although topically applied MDs in the form of gels and creams might be used on damaged skin, their composition is often similar to that of cosmetic products applicable to intact skin, especially in terms of preservatives and fragrances. However, unlike cosmetics, these products are not subject to compound‐specific restrictions when used in MDs.ObjectiveThis study aimed to identify and quantify preservatives and fragrances in topically applied MDs and assess their safety towards the Cosmetic Regulation (EC) 1223/2009.MethodSixty‐nine MDs available on the EU market were subjected to previously validated liquid chromatography tandem mass spectrometry (LC–MS/MS) and gas chromatography–mass spectrometry (GC–MS) methods to identify and quantify occurring preservatives and fragrances.ResultsFindings revealed that 32% of the examined MDs did not provide comprehensive ingredient lists, leaving users uninformed about potential risks associated with product use. Furthermore, 30% of these MDs would not meet safety standards for cosmetic products and, most significantly, 13% of the analysed samples contained ingredients that are prohibited in leave‐on cosmetics.ConclusionResults highlight the pressing demand for more stringent requirements regarding the labelling and composition of MDs to enhance patient safety. Improved regulation and transparency can mitigate potential risks associated with the use of topically applied MDs. 10.1111/cod.14533 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1111/cod.14533 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_cod_14533 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt Contact Dermatitis Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation Ania Stras Aleksandra Grassmann Peter Van Campenhout Eric Deconinck Tamara Vanhaecke Bart Desmedt Contact Dermatitis AbstractIntroductionMedical devices (MDs) have a long history of use, and come with regulatory frameworks to ensure user safety. Although topically applied MDs in the form of gels and creams might be used on damaged skin, their composition is often similar to that of cosmetic products applicable to intact skin, especially in terms of preservatives and fragrances. However, unlike cosmetics, these products are not subject to compound‐specific restrictions when used in MDs.ObjectiveThis study aimed to identify and quantify preservatives and fragrances in topically applied MDs and assess their safety towards the Cosmetic Regulation (EC) 1223/2009.MethodSixty‐nine MDs available on the EU market were subjected to previously validated liquid chromatography tandem mass spectrometry (LC–MS/MS) and gas chromatography–mass spectrometry (GC–MS) methods to identify and quantify occurring preservatives and fragrances.ResultsFindings revealed that 32% of the examined MDs did not provide comprehensive ingredient lists, leaving users uninformed about potential risks associated with product use. Furthermore, 30% of these MDs would not meet safety standards for cosmetic products and, most significantly, 13% of the analysed samples contained ingredients that are prohibited in leave‐on cosmetics.ConclusionResults highlight the pressing demand for more stringent requirements regarding the labelling and composition of MDs to enhance patient safety. Improved regulation and transparency can mitigate potential risks associated with the use of topically applied MDs. 10.1111/cod.14533 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Analysis of preservatives and fragrances in topical medical devices: The need for more stringent regulation |
| topic | Contact Dermatitis |
| url | https://onlinelibrary.wiley.com/doi/10.1111/cod.14533 |